RENO, NV [April 2, 2024] – Prescription Care Management (PCM), a leading healthcare technology company, is pleased to announce its latest webinar.
Webinar: Preparing Self-Funded Plans for the Game-Changing Impact of Biosimilars
Wednesday, April 17
10:00 am PT / 1:00 pm ET
Description: This webinar, featuring PCM’s Chief Pharmacist, Dr. David Merritt, PharmD, RPh, will review the benefits of biosimilar adoption and explore why we aren’t seeing more of an impact yet. Dr. Merritt will take a closer look at how biosimilar adoption will affect plan and patient costs, breaking down spending on an actual group. We will also discuss ways to increase adoption through physician and patient education.
Key Takeaways:
- Understanding the cost and clinical impact of biosimilars.
- Identifying key hurdles to widespread adoption.
- Exploring the future of biosimilars in self-funded health plans.
Who Should Attend:
- Brokers
- Consultants
- TPAs, Health Plans, and PBMs
- Self-Insured Plans
About PCM: PCM is an innovative health tech company dedicated to solving inefficiencies in the health benefits space. Guided by the client’s unique needs, PCM’s proprietary technology provides brokers, TPAs, health plans, and others with visibility, insights, and tools to build sustainable, client-centric benefit programs. Visit PCM at www.pcmsavings.com and follow on LinkedIn.